We found the presence of hepatitis C virus (HCV) infection in liver tissues of hepatocellular carcinoma (HCC) patients who had antibodies to HCV but no serological markers for hepatitis B virus infection by the sensitive reverse transcription/polymerase chain reaction (R/PCR) method. The primers used were derived from the non-structural (NS) 3 and/or the structural (C/E) region. Amplified cDNA sequences of HCV were detected in either cancerous or noncancerous portion of liver tissues from four out of eight HCC patients with primers of NS3 region. Similar but less efficient results were obtained with primers of C/E region. These results indicate that HCV persists in the liver tissue of HCC. A possible role of persistent infection of HCV for the development of HCC is discussed.
SUMMARY:
We found the presence of hepatitis C virus (HCV) infection in liver tissues of hepatocellular carcinoma (HCC) patients who had antibodies to HCV but no serological markers for hepatitis B virus infection by the sensitive reverse transcription/polymerase chain reaction (R/PCR) method. The primers used were derived from the non-structural (NS) 3 and/or the structural (C/E) region. Amplified cDNA sequences of HCV were detected in either cancerous or noncancerous portion of liver tissues from four out of eight HCC patients with primers of NS3 region. Similar but less efficient results were obtained with primers of C/E region. These results indicate that HCV persists in the liver tissue of HCC. A possible role of persistent infection of HCV for the development of HCC is discussed. Fig. 1 . Detection of cDNA sequences of the HCV genome from liver tissues of HCCs. RNAs were prepared from cancerous (T) and noncancerous (N) portions of autopsy samples of HCC patients who had antibodies to HCV. Products of R/PCR using either NS3 or C/E primers were electrophoresed on a 2% agarose gel, and analyzed by Southern blot hybridization with a probe encompassing either NS3 (A) or C/E region (B). HCC patients were indicated by numbers 1-8. The arrow indicates the position of the amplified 440 by cDNA fragment of NS3 or C/E region.
NS3 regoin was about 620 by cDNA fragment from pU1-4652 clone digested with EcoRI and Pst I (9) . The probe in the CIE region was about 1,300 by cDNA fragment from pSR316 digested with Kpn I and Pst I (S. Harada et al., manuscript submitted). When NS3 region was examined as a target of RIPCR (Fig. 1A) , HCV sequences were detected in four samples of the non-cancerous portion (patients Nos. 1, 2, 4, and 8) from eight HCC patients. Amplified cDNA sequences of HCV were also detected in two samples of cancerous portion (patient No. 2 and 8). When C/E region was examined (Fig. 1B) , three samples of either cancerous or non-cancerous portion from eight HCCs were also positive (patients Nos. 1, 2 and 4), which is in good agreement with the results with NS3 region.
The efficiency of detection with primers of NS3 region was better for the sample from patient No. 8 than with those of CIE region. This may have been due to the different degrees of conservation of nucleotide sequence between the NS3 and structural protein region (9) Over 50% of HCV infections develop eventually into chronic hepatitis (14) .
Persistent infection of long duration of the liver may cause repeated tissue injury and regeneration of hepatocytes. It may finally lead to the development of HCC through cirrhosis (15) . Our present data indicate that HCV persists in cancerous and non-cancerous liver tissues of HCC. It is noteworthy that patients Nos. 1, 4 and 8 had previous histories of blood transfusion approximately 30 years ago. Most likely, they were infected with HCV on these occasions (16) . These results as well as such a high prevalence of HCV antibody in non-B HCC patients (6) suggest that HCV is an important factor in pathogenesis of HCC.
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